Compounds > oxiconazole
Page last updated: 2024-08-23

oxiconazole and bay h 4502

oxiconazole has been researched along with bay h 4502 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19906 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A1
Bron, S; Chambon, M; Colau, D; Majjigapu, SR; Michielin, O; Pilotte, L; Röhrig, UF; Turcatti, G; Van den Eynde, BJ; Vogel, P; Zoete, V1
Bozkurt, M; Gürer, MA; Kuştimur, S1
Frosch, PJ; Raulin, C1
Cauwenbergh, G1
Reckers-Czaschka, R; Wagner, W1
Abbott, AB; Odds, FC; Webster, CE1
Polak, A1

Trials

1 trial(s) available for oxiconazole and bay h 4502

ArticleYear
[Oxiconazole in dermatomycosis--a double-blind, randomized therapy compared with bifonazole].
    Mykosen, 1987, Volume: 30, Issue:10

    Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Double-Blind Method; Erythrasma; Female; Humans; Imidazoles; Male; Random Allocation

1987

Other Studies

7 other study(ies) available for oxiconazole and bay h 4502

ArticleYear
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2012
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    European journal of medicinal chemistry, 2014, Sep-12, Volume: 84

    Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship

2014
[In vitro susceptibility of dermatophyte strains to imidazole derivatives].
    Mikrobiyoloji bulteni, 1989, Volume: 23, Issue:1

    Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Humans; Imidazoles; Miconazole

1989
Contact allergy to imidazole antimycotics.
    Contact dermatitis, 1988, Volume: 18, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Chemical Phenomena; Chemistry; Clotrimazole; Drug Eruptions; Econazole; Female; Humans; Imidazoles; Male; Miconazole; Middle Aged; Prospective Studies

1988
New and prospective developments in antifungal drugs.
    Acta dermato-venereologica. Supplementum, 1986, Volume: 121

    Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles

1986
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles

1984
Antifungal activity of four antifungal drugs in the cutaneous retention time test.
    Sabouraudia, 1984, Volume: 22, Issue:6

    Topics: Animals; Antifungal Agents; Guinea Pigs; Imidazoles; Morpholines; Ointments; Thiocarbamates; Tinea; Trichophyton

1984